Current Collaborators In 'For Professionals' For professionalsCurrent CollaboratorsApply to Collaborate with Glo-BNHL Back to 'Glo-BNHL' Open to recruitment Treatment Arm I: Odronextamab (Bispecific antibody), Regeneron Pharmaceuticals Inc. Treatment Arm II: Loncastuximab tesirine (Antibody Drug Conjugate) with standard chemotherapy, ADC Therapeutics SA